Torque Taps Thomas Andresen for Chief Scientific Officer

Xconomy Boston — 

Thomas Andresen has been appointed chief scientific officer of immune-oncology therapies developer Torque. Andresen comes to the Cambridge, MA-based company from the Technical University of Denmark, where he was a professor in the department of micro-and nanotechnology. Andresen is also a Torque co-founder. Torque, which raised $25 million in a Series A round of financing last year, is developing cell therapies intended to offer a more targeted and durable tumor-killing approach.